Adiponectin Receptor 1 (ADIPOR1) rs1342387 Polymorphism and Risk of Cancer: a Meta-analysis |
Yu, Li-Xiang
(Department of Breast Diseases, The Second Hospital of Shandong University)
Zhou, Nan-Nan (Department of Aged Cardiovascular Diseases, Shandong Provincial Hospital Affiliated to Shandong University) Liu, Li-Yuan (Epidemiology Institute, School of Public Health, Shandong University) Wang, Fei (Department of Breast Diseases, The Second Hospital of Shandong University) Ma, Zhong-Bing (Department of Breast Diseases, The Second Hospital of Shandong University) Li, Jie (Nursing Psychology, School of Nursing, Shandong University) Yu, Zhi-Gang (Department of Breast Diseases, The Second Hospital of Shandong University) |
1 | Vucenik I, Stains JP (2012). Obesity and cancer risk: evidence, mechanisms, and recommendations. Ann N Y Acad Sci, 1271, 37-43. DOI ScienceOn |
2 | Wells GA, Shea B, O'Connell D, et al (2000). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. [cited 28 October 2013]. Available from http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. |
3 | Xu Y, He B, Pan Y, et al (2013). The roles of ADIPOQ genetic variations in cancer risk: evidence from published studies. Mol Biol Rep, 40, 1135-44. DOI ScienceOn |
4 | Yang Y, Zhang F, Ding R, et al (2013). ADIPOQ gene polymorphisms and cancer risk: a meta-analysis. Cytokine, 61, 565-71. DOI ScienceOn |
5 | Zhang Y, Feng Q, Liu C, et al (2012). Relationship between polymorphism sites of adiponection and it's receptor gene and the susceptibility of colorectal cancer. J Jiangsu University, 336-41. |
6 | Zhou, W, Liu, Y, Zhong, DW (2013). Adiponectin (ADIPOQ) rs2241766 G/T polymorphism is associated with risk of cancer: evidence from a meta-analysis. Tumour Biol, 34, 493-504. DOI ScienceOn |
7 | Ziemke F, Mantzoros CS (2010). Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr, 91, 258-61. DOI ScienceOn |
8 | An W, Bai Y, Deng SX, et al (2012). Adiponectin levels in patients with colorectal cancer and adenoma: a metaanalysis. Eur J Cancer Prev, 21, 126-33. DOI |
9 | Beebe-Dimmer JL, Zuhlke KA, Ray AM, et al (2010). Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans. Prostate Cancer Prostatic Dis, 13, 362-8. DOI ScienceOn |
10 | Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101. DOI ScienceOn |
11 | Crimmins NA, Martin LJ (2007). Polymorphisms in adiponectin receptor genes ADIPOR1 and ADIPOR2 and insulin resistance. Obes Rev, 8, 419-23. DOI ScienceOn |
12 | Dalamaga M, Diakopoulos KN, Mantzoros CS (2012). The role of adiponectin in cancer: a review of current evidence. Endocr Rev, 33, 547-94. DOI |
13 | Finucane MM, Stevens GA, Cowan MJ, et al (2011). National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet, 377, 557-67. DOI ScienceOn |
14 | DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7, 177-88. DOI ScienceOn |
15 | Egger M, Davey SG, Schneider M, et al (1997). Bias in metaanalysis detected by a simple, graphical test. BMJ, 315, 629-34. DOI ScienceOn |
16 | Fan HJ, Wen ZF, Xu BL, et al (2013). Three adiponectin rs1501299G/T, rs822395A/C, and rs822396A/G polymorphisms and risk of cancer development: a metaanalysis. Tumour Biol, 34, 769-78. DOI ScienceOn |
17 | Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. DOI ScienceOn |
18 | He B, Pan Y, Zhang Y, et al (2011). Effects of genetic variations in the adiponectin pathway genes on the risk of colorectal cancer in the Chinese population. BMC Med Genet, 12, 94. |
19 | Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60. DOI ScienceOn |
20 | Inoue M, Tsugane S (2012). Insulin resistance and cancer: epidemiological evidence. Endocr Relat Cancer, 19, 1-8. DOI |
21 | Ishikawa M, Kitayama J, Yamauchi T, et al (2007). Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2. Cancer Sci, 98, 1120-7. DOI ScienceOn |
22 | Joshi RK, Lee SA (2014). Obesity related adipokines and colorectal cancer: a review and meta-analysis. Asian Pac J Cancer Prev, 15, 397-405. 과학기술학회마을 DOI ScienceOn |
23 | Kim AY, Lee YS, Kim KH, et al (2010). Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2- mediated AMPK activation. Mol Endocrinol, 24, 1441-52. DOI ScienceOn |
24 | Kaklamani V, Yi N, Zhang K, et al (2011). Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk. Metabolism, 60, 1234-43. DOI ScienceOn |
25 | Kaklamani VG, Sadim M, Hsi A, et al (2008). Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. Cancer Res, 68, 3178-84. DOI ScienceOn |
26 | Kaklamani VG, Wisinski KB, Sadim M, et al (2008). Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA, 300, 1523-31. DOI ScienceOn |
27 | Liu LY, Wang M, Ma ZB, et al (2013). The role of adiponectin in breast cancer: a meta-analysis. PLoS One, 8, 73183. DOI |
28 | Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48. |
29 | Nordmann AJ, Kasenda B, Briel M (2012). Meta-analyses: what they can and cannot do. Swiss Med Wkly, 142, 13518. |
30 | Mather KJ, Christophi CA, Jablonski KA, et al (2012). Common variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/2), adiponectin concentrations, and diabetes incidence in the Diabetes Prevention Program. Diabet Med, 29, 1579-88. DOI ScienceOn |
31 | Ou Y (2012). The association of polymorphisms on ADIPOQ and ADIPORl with risk and prognosis of cancer. second military medical university, shanghai, China, 2012. 24-62 |
32 | Siitonen N, Pulkkinen L, Mager U, et al (2006). Association of sequence variations in the gene encoding adiponectin receptor 1 (ADIPOR1) with body size and insulin levels. The Finnish Diabetes Prevention Study. Diabetologia, 49, 1795-805. DOI |
33 | Ouchi N, Kihara S, Arita Y, et al (2000). Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NFkappaB signaling through a cAMP-dependent pathway. Circulation, 102, 1296-301. DOI ScienceOn |
34 | Paz-Filho G, Lim EL, Wong ML, et al (2011). Associations between adipokines and obesity-related cancer. Front Biosci (Landmark Ed), 16, 1634-50. DOI |
35 | Renehan AG, Tyson M, Egger M, et al (2008). Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet, 371, 569-78. DOI ScienceOn |
36 | Tsuchida A, Yamauchi T, Ito Y, et al (2004). Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem, 279, 30817-22. DOI ScienceOn |
37 | Tsukada T, Fushida S, Harada S, et al (2011). Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer. J Exp Clin Cancer Res, 30, 107. DOI |
38 | Barb D, Williams CJ, Neuwirth AK, Mantzoros CS (2007). Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr, 86, s858-66. |
39 | Liu L, Zhong R, Wei S, et al (2011). Interactions between genetic variants in the adiponectin, adiponectin receptor 1 and environmental factors on the risk of colorectal cancer. PLoS One, 6, 27301. DOI |